APO Research
Talk to an analyst

APO RESEARCH · REPORT

Absorbable Hemostatic Materials

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Absorbable Hemostatic Materials Market Analysis and Forecast 2026-2032

19 December 2025192 pages

Choose your research edition.

Industry ResearchAbsorbable Hemostatic Materials Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Absorbable Hemostatic Materials Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Absorbable Hemostatic Materials Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Absorbable Hemostatic Materials Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Absorbable Hemostatic Materials Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Absorbable Hemostatic Materials market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Absorbable Hemostatic Materials is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Absorbable Hemostatic Materials is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Absorbable Hemostatic Materials is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Absorbable Hemostatic Materials is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Absorbable Hemostatic Materials include Johnson & Johnson, Guizhou Jin Jiu Biotech, B.Braun, Beijing Taikesiman, Beijing Datsing Bio-tech, Baxter, Zhonghui Shengxi, Saikesaisi Holdings Group and Meril Life Sciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Absorbable Hemostatic Materials, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Absorbable Hemostatic Materials, also provides the revenue of main regions and countries. Of the upcoming market potential for Absorbable Hemostatic Materials, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Absorbable Hemostatic Materials revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Absorbable Hemostatic Materials market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Absorbable Hemostatic Materials revenue, projected growth trends, production technology, application and end-user industry.

Absorbable Hemostatic Materials Segment by Company

Johnson & Johnson

Guizhou Jin Jiu Biotech

B.Braun

Beijing Taikesiman

Beijing Datsing Bio-tech

Baxter

Zhonghui Shengxi

Saikesaisi Holdings Group

Meril Life Sciences

GELITA MEDICAL

Foryou Medical

Curasan AG

Cura Medical

Biotemed

BD

Absorbable Hemostatic Materials Segment by Type

Absorbable Hemostat Powder

Absorbable Hemostat Gauze

Absorbable Hemostat Gelatin Sponge

Others

Absorbable Hemostatic Materials Segment by Application

Hospitals

Clinics

Others

Absorbable Hemostatic Materials Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Absorbable Hemostatic Materials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Absorbable Hemostatic Materials and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Absorbable Hemostatic Materials.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Absorbable Hemostatic Materials in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Absorbable Hemostatic Materials company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Absorbable Hemostatic Materials revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Absorbable Hemostatic Materials Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Absorbable Hemostat Powder Major Player Table 3. Absorbable Hemostat Gauze Major Player Table 4. Absorbable Hemostat Gelatin Sponge Major Player Table 5. Others Major Player Table 6. Global Absorbable Hemostatic Materials Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospitals Major Player Table 8. Clinics Major Player Table 9. Others Major Player Table 10. Absorbable Hemostatic Materials Industry Trends Table 11. Absorbable Hemostatic Materials Industry Drivers Table 12. Absorbable Hemostatic Materials Industry Opportunities and Challenges Table 13. Absorbable Hemostatic Materials Industry Restraints Table 14. Global Absorbable Hemostatic Materials Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Absorbable Hemostatic Materials Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Absorbable Hemostatic Materials Market Share by Region (2021-2026) Table 17. Global Absorbable Hemostatic Materials Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Absorbable Hemostatic Materials Market Share by Region (2027-2032) Table 19. Global Absorbable Hemostatic Materials Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Absorbable Hemostatic Materials Revenue Market Share by Players (2021-2026) Table 21. Global Absorbable Hemostatic Materials Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Absorbable Hemostatic Materials Key Players Headquarters & Area Served Table 23. Global Absorbable Hemostatic Materials Players, Product Type & Application Table 24. Global Absorbable Hemostatic Materials Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Absorbable Hemostatic Materials by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Absorbable Hemostatic Materials Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Absorbable Hemostatic Materials Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Absorbable Hemostatic Materials Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Absorbable Hemostatic Materials Revenue Market Share by Type (2021-2026) Table 31. Global Absorbable Hemostatic Materials Revenue Market Share by Type (2027-2032) Table 32. Global Absorbable Hemostatic Materials Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Absorbable Hemostatic Materials Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Absorbable Hemostatic Materials Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Absorbable Hemostatic Materials Revenue Market Share by Application (2021-2026) Table 36. Global Absorbable Hemostatic Materials Revenue Market Share by Application (2027-2032) Table 37. Johnson & Johnson Company Information Table 38. Johnson & Johnson Business Overview Table 39. Johnson & Johnson Absorbable Hemostatic Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Johnson & Johnson Absorbable Hemostatic Materials Product Portfolio Table 41. Johnson & Johnson Recent Development Table 42. Guizhou Jin Jiu Biotech Company Information Table 43. Guizhou Jin Jiu Biotech Business Overview Table 44. Guizhou Jin Jiu Biotech Absorbable Hemostatic Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Guizhou Jin Jiu Biotech Absorbable Hemostatic Materials Product Portfolio Table 46. Guizhou Jin Jiu Biotech Recent Development Table 47. B.Braun Company Information Table 48. B.Braun Business Overview Table 49. B.Braun Absorbable Hemostatic Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. B.Braun Absorbable Hemostatic Materials Product Portfolio Table 51. B.Braun Recent Development Table 52. Beijing Taikesiman Company Information Table 53. Beijing Taikesiman Business Overview Table 54. Beijing Taikesiman Absorbable Hemostatic Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Beijing Taikesiman Absorbable Hemostatic Materials Product Portfolio Table 56. Beijing Taikesiman Recent Development Table 57. Beijing Datsing Bio-tech Company Information Table 58. Beijing Datsing Bio-tech Business Overview Table 59. Beijing Datsing Bio-tech Absorbable Hemostatic Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Beijing Datsing Bio-tech Absorbable Hemostatic Materials Product Portfolio Table 61. Beijing Datsing Bio-tech Recent Development Table 62. Baxter Company Information Table 63. Baxter Business Overview Table 64. Baxter Absorbable Hemostatic Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Baxter Absorbable Hemostatic Materials Product Portfolio Table 66. Baxter Recent Development Table 67. Zhonghui Shengxi Company Information Table 68. Zhonghui Shengxi Business Overview Table 69. Zhonghui Shengxi Absorbable Hemostatic Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Zhonghui Shengxi Absorbable Hemostatic Materials Product Portfolio Table 71. Zhonghui Shengxi Recent Development Table 72. Saikesaisi Holdings Group Company Information Table 73. Saikesaisi Holdings Group Business Overview Table 74. Saikesaisi Holdings Group Absorbable Hemostatic Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Saikesaisi Holdings Group Absorbable Hemostatic Materials Product Portfolio Table 76. Saikesaisi Holdings Group Recent Development Table 77. Meril Life Sciences Company Information Table 78. Meril Life Sciences Business Overview Table 79. Meril Life Sciences Absorbable Hemostatic Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Meril Life Sciences Absorbable Hemostatic Materials Product Portfolio Table 81. Meril Life Sciences Recent Development Table 82. GELITA MEDICAL Company Information Table 83. GELITA MEDICAL Business Overview Table 84. GELITA MEDICAL Absorbable Hemostatic Materials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. GELITA MEDICAL Absorbable Hemostatic Materials Product Portfolio Table 86. GELITA MEDICAL Recent Development Table 87. Foryou Medical Company Information Table 88. Foryou Medical Business Overview Table 89. Foryou Medical Absorbable Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Foryou Medical Absorbable Hemostatic Materials Product Portfolio Table 91. Foryou Medical Recent Development Table 92. Curasan AG Company Information Table 93. Curasan AG Business Overview Table 94. Curasan AG Absorbable Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Curasan AG Absorbable Hemostatic Materials Product Portfolio Table 96. Curasan AG Recent Development Table 97. Cura Medical Company Information Table 98. Cura Medical Business Overview Table 99. Cura Medical Absorbable Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Cura Medical Absorbable Hemostatic Materials Product Portfolio Table 101. Cura Medical Recent Development Table 102. Biotemed Company Information Table 103. Biotemed Business Overview Table 104. Biotemed Absorbable Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Biotemed Absorbable Hemostatic Materials Product Portfolio Table 106. Biotemed Recent Development Table 107. BD Company Information Table 108. BD Business Overview Table 109. BD Absorbable Hemostatic Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. BD Absorbable Hemostatic Materials Product Portfolio Table 111. BD Recent Development Table 112. North America Absorbable Hemostatic Materials Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Absorbable Hemostatic Materials Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Absorbable Hemostatic Materials Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Absorbable Hemostatic Materials Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Absorbable Hemostatic Materials Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Absorbable Hemostatic Materials Revenue by Country (2021-2026) & (US$ Million) Table 118. North America Absorbable Hemostatic Materials Revenue by Country (US$ Million) & (2027-2032) Table 119. Europe Absorbable Hemostatic Materials Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe Absorbable Hemostatic Materials Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe Absorbable Hemostatic Materials Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Absorbable Hemostatic Materials Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Absorbable Hemostatic Materials Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe Absorbable Hemostatic Materials Revenue by Country (2021-2026) & (US$ Million) Table 125. Europe Absorbable Hemostatic Materials Revenue by Country (US$ Million) & (2027-2032) Table 126. China Absorbable Hemostatic Materials Revenue by Type (2021-2026) & (US$ Million) Table 127. China Absorbable Hemostatic Materials Revenue by Type (2027-2032) & (US$ Million) Table 128. China Absorbable Hemostatic Materials Revenue by Application (2021-2026) & (US$ Million) Table 129. China Absorbable Hemostatic Materials Revenue by Application (2027-2032) & (US$ Million) Table 130. Asia Absorbable Hemostatic Materials Revenue by Type (2021-2026) & (US$ Million) Table 131. Asia Absorbable Hemostatic Materials Revenue by Type (2027-2032) & (US$ Million) Table 132. Asia Absorbable Hemostatic Materials Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia Absorbable Hemostatic Materials Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Absorbable Hemostatic Materials Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Asia Absorbable Hemostatic Materials Revenue by Region (US$ Million) & (2021-2026) Table 136. Asia Absorbable Hemostatic Materials Revenue by Region (US$ Million) & (2027-2032) Table 137. SAMEA Absorbable Hemostatic Materials Revenue by Type (2021-2026) & (US$ Million) Table 138. SAMEA Absorbable Hemostatic Materials Revenue by Type (2027-2032) & (US$ Million) Table 139. SAMEA Absorbable Hemostatic Materials Revenue by Application (2021-2026) & (US$ Million) Table 140. SAMEA Absorbable Hemostatic Materials Revenue by Application (2027-2032) & (US$ Million) Table 141. SAMEA Absorbable Hemostatic Materials Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. SAMEA Absorbable Hemostatic Materials Revenue by Country (2021-2026) & (US$ Million) Table 143. SAMEA Absorbable Hemostatic Materials Revenue by Country (US$ Million) & (2027-2032) Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Absorbable Hemostatic Materials Image Figure 2. Global Absorbable Hemostatic Materials Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Absorbable Hemostatic Materials Market Size Share 2021 VS 2025 VS 2032 Figure 4. Absorbable Hemostat Powder Image Figure 5. Absorbable Hemostat Gauze Image Figure 6. Absorbable Hemostat Gelatin Sponge Image Figure 7. Others Image Figure 8. Global Absorbable Hemostatic Materials Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Absorbable Hemostatic Materials Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospitals Image Figure 11. Clinics Image Figure 12. Others Image Figure 13. Global Absorbable Hemostatic Materials Market Size (US$ Million) & (2021-2032) Figure 14. Global Absorbable Hemostatic Materials Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Absorbable Hemostatic Materials Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Absorbable Hemostatic Materials Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Absorbable Hemostatic Materials Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Absorbable Hemostatic Materials Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Absorbable Hemostatic Materials Revenue Market Share by Type (2021-2032) Figure 21. Global Absorbable Hemostatic Materials Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Absorbable Hemostatic Materials Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Absorbable Hemostatic Materials Revenue Market Share by Application (2021-2032) Figure 24. North America Absorbable Hemostatic Materials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Absorbable Hemostatic Materials Revenue Share by Type (2021-2032) Figure 26. North America Absorbable Hemostatic Materials Revenue Share by Application (2021-2032) Figure 27. North America Absorbable Hemostatic Materials Revenue Share by Country (2021-2032) Figure 28. United States Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Absorbable Hemostatic Materials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Absorbable Hemostatic Materials Revenue Share by Type (2021-2032) Figure 33. Europe Absorbable Hemostatic Materials Revenue Share by Application (2021-2032) Figure 34. Europe Absorbable Hemostatic Materials Revenue Share by Country (2021-2032) Figure 35. Germany Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Absorbable Hemostatic Materials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Absorbable Hemostatic Materials Revenue Share by Type (2021-2032) Figure 45. China Absorbable Hemostatic Materials Revenue Share by Application (2021-2032) Figure 46. Asia Absorbable Hemostatic Materials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Absorbable Hemostatic Materials Revenue Share by Type (2021-2032) Figure 48. Asia Absorbable Hemostatic Materials Revenue Share by Application (2021-2032) Figure 49. Asia Absorbable Hemostatic Materials Revenue Share by Region (2021-2032) Figure 50. Japan Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Absorbable Hemostatic Materials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Absorbable Hemostatic Materials Revenue Share by Type (2021-2032) Figure 58. SAMEA Absorbable Hemostatic Materials Revenue Share by Application (2021-2032) Figure 59. SAMEA Absorbable Hemostatic Materials Revenue Share by Country (2021-2032) Figure 60. Brazil Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Absorbable Hemostatic Materials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Absorbable Hemostat Powder
  • Absorbable Hemostat Gauze
  • Absorbable Hemostat Gelatin Sponge
  • Others
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Johnson & Johnson
  • Guizhou Jin Jiu Biotech
  • B.Braun
  • Beijing Taikesiman
  • Beijing Datsing Bio-tech
  • Baxter
  • Zhonghui Shengxi
  • Saikesaisi Holdings Group
  • Meril Life Sciences
  • GELITA MEDICAL
  • Foryou Medical
  • Curasan AG
  • Cura Medical
  • Biotemed
  • BD

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Absorbable Hemostatic Materials Market by Type
  3. 1.2.1 Global Absorbable Hemostatic Materials Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Absorbable Hemostat Powder
  5. 1.2.3 Absorbable Hemostat Gauze
  6. 1.2.4 Absorbable Hemostat Gelatin Sponge
  7. 1.2.5 Others
  8. 1.3 Absorbable Hemostatic Materials Market by Application
  9. 1.3.1 Global Absorbable Hemostatic Materials Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals
  11. 1.3.3 Clinics
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Absorbable Hemostatic Materials Market Dynamics
  1. 2.1 Absorbable Hemostatic Materials Industry Trends
  2. 2.2 Absorbable Hemostatic Materials Industry Drivers
  3. 2.3 Absorbable Hemostatic Materials Industry Opportunities and Challenges
  4. 2.4 Absorbable Hemostatic Materials Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Absorbable Hemostatic Materials Market Perspective (2021-2032)
  2. 3.2 Global Absorbable Hemostatic Materials Growth Trends by Region
  3. 3.2.1 Global Absorbable Hemostatic Materials Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Absorbable Hemostatic Materials Market Size by Region (2021-2026)
  5. 3.2.3 Global Absorbable Hemostatic Materials Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Absorbable Hemostatic Materials Revenue by Players
  2. 4.1.1 Global Absorbable Hemostatic Materials Revenue by Players (2021-2026)
  3. 4.1.2 Global Absorbable Hemostatic Materials Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Absorbable Hemostatic Materials Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Absorbable Hemostatic Materials Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Absorbable Hemostatic Materials Key Players Headquarters & Area Served
  7. 4.4 Global Absorbable Hemostatic Materials Players, Product Type & Application
  8. 4.5 Global Absorbable Hemostatic Materials Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Absorbable Hemostatic Materials Market CR5 and HHI
  11. 4.6.3 2025 Absorbable Hemostatic Materials Tier 1, Tier 2, and Tier 3
5 Absorbable Hemostatic Materials Market Size by Type
  1. 5.1 Global Absorbable Hemostatic Materials Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Absorbable Hemostatic Materials Revenue by Type (2021-2032)
  3. 5.3 Global Absorbable Hemostatic Materials Revenue Market Share by Type (2021-2032)
6 Absorbable Hemostatic Materials Market Size by Application
  1. 6.1 Global Absorbable Hemostatic Materials Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Absorbable Hemostatic Materials Revenue by Application (2021-2032)
  3. 6.3 Global Absorbable Hemostatic Materials Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson Absorbable Hemostatic Materials Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Guizhou Jin Jiu Biotech
  8. 7.2.1 Guizhou Jin Jiu Biotech Company Information
  9. 7.2.2 Guizhou Jin Jiu Biotech Business Overview
  10. 7.2.3 Guizhou Jin Jiu Biotech Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Guizhou Jin Jiu Biotech Absorbable Hemostatic Materials Product Portfolio
  12. 7.2.5 Guizhou Jin Jiu Biotech Recent Developments
  13. 7.3 B.Braun
  14. 7.3.1 B.Braun Company Information
  15. 7.3.2 B.Braun Business Overview
  16. 7.3.3 B.Braun Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  17. 7.3.4 B.Braun Absorbable Hemostatic Materials Product Portfolio
  18. 7.3.5 B.Braun Recent Developments
  19. 7.4 Beijing Taikesiman
  20. 7.4.1 Beijing Taikesiman Company Information
  21. 7.4.2 Beijing Taikesiman Business Overview
  22. 7.4.3 Beijing Taikesiman Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Beijing Taikesiman Absorbable Hemostatic Materials Product Portfolio
  24. 7.4.5 Beijing Taikesiman Recent Developments
  25. 7.5 Beijing Datsing Bio-tech
  26. 7.5.1 Beijing Datsing Bio-tech Company Information
  27. 7.5.2 Beijing Datsing Bio-tech Business Overview
  28. 7.5.3 Beijing Datsing Bio-tech Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Beijing Datsing Bio-tech Absorbable Hemostatic Materials Product Portfolio
  30. 7.5.5 Beijing Datsing Bio-tech Recent Developments
  31. 7.6 Baxter
  32. 7.6.1 Baxter Company Information
  33. 7.6.2 Baxter Business Overview
  34. 7.6.3 Baxter Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Baxter Absorbable Hemostatic Materials Product Portfolio
  36. 7.6.5 Baxter Recent Developments
  37. 7.7 Zhonghui Shengxi
  38. 7.7.1 Zhonghui Shengxi Company Information
  39. 7.7.2 Zhonghui Shengxi Business Overview
  40. 7.7.3 Zhonghui Shengxi Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Zhonghui Shengxi Absorbable Hemostatic Materials Product Portfolio
  42. 7.7.5 Zhonghui Shengxi Recent Developments
  43. 7.8 Saikesaisi Holdings Group
  44. 7.8.1 Saikesaisi Holdings Group Company Information
  45. 7.8.2 Saikesaisi Holdings Group Business Overview
  46. 7.8.3 Saikesaisi Holdings Group Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Saikesaisi Holdings Group Absorbable Hemostatic Materials Product Portfolio
  48. 7.8.5 Saikesaisi Holdings Group Recent Developments
  49. 7.9 Meril Life Sciences
  50. 7.9.1 Meril Life Sciences Company Information
  51. 7.9.2 Meril Life Sciences Business Overview
  52. 7.9.3 Meril Life Sciences Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Meril Life Sciences Absorbable Hemostatic Materials Product Portfolio
  54. 7.9.5 Meril Life Sciences Recent Developments
  55. 7.10 GELITA MEDICAL
  56. 7.10.1 GELITA MEDICAL Company Information
  57. 7.10.2 GELITA MEDICAL Business Overview
  58. 7.10.3 GELITA MEDICAL Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  59. 7.10.4 GELITA MEDICAL Absorbable Hemostatic Materials Product Portfolio
  60. 7.10.5 GELITA MEDICAL Recent Developments
  61. 7.11 Foryou Medical
  62. 7.11.1 Foryou Medical Company Information
  63. 7.11.2 Foryou Medical Business Overview
  64. 7.11.3 Foryou Medical Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Foryou Medical Absorbable Hemostatic Materials Product Portfolio
  66. 7.11.5 Foryou Medical Recent Developments
  67. 7.12 Curasan AG
  68. 7.12.1 Curasan AG Company Information
  69. 7.12.2 Curasan AG Business Overview
  70. 7.12.3 Curasan AG Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Curasan AG Absorbable Hemostatic Materials Product Portfolio
  72. 7.12.5 Curasan AG Recent Developments
  73. 7.13 Cura Medical
  74. 7.13.1 Cura Medical Company Information
  75. 7.13.2 Cura Medical Business Overview
  76. 7.13.3 Cura Medical Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Cura Medical Absorbable Hemostatic Materials Product Portfolio
  78. 7.13.5 Cura Medical Recent Developments
  79. 7.14 Biotemed
  80. 7.14.1 Biotemed Company Information
  81. 7.14.2 Biotemed Business Overview
  82. 7.14.3 Biotemed Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Biotemed Absorbable Hemostatic Materials Product Portfolio
  84. 7.14.5 Biotemed Recent Developments
  85. 7.15 BD
  86. 7.15.1 BD Company Information
  87. 7.15.2 BD Business Overview
  88. 7.15.3 BD Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  89. 7.15.4 BD Absorbable Hemostatic Materials Product Portfolio
  90. 7.15.5 BD Recent Developments
8 North America
  1. 8.1 North America Absorbable Hemostatic Materials Revenue (2021-2032)
  2. 8.2 North America Absorbable Hemostatic Materials Revenue by Type (2021-2032)
  3. 8.2.1 North America Absorbable Hemostatic Materials Revenue by Type (2021-2026)
  4. 8.2.2 North America Absorbable Hemostatic Materials Revenue by Type (2027-2032)
  5. 8.3 North America Absorbable Hemostatic Materials Revenue Share by Type (2021-2032)
  6. 8.4 North America Absorbable Hemostatic Materials Revenue by Application (2021-2032)
  7. 8.4.1 North America Absorbable Hemostatic Materials Revenue by Application (2021-2026)
  8. 8.4.2 North America Absorbable Hemostatic Materials Revenue by Application (2027-2032)
  9. 8.5 North America Absorbable Hemostatic Materials Revenue Share by Application (2021-2032)
  10. 8.6 North America Absorbable Hemostatic Materials Revenue by Country
  11. 8.6.1 North America Absorbable Hemostatic Materials Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Absorbable Hemostatic Materials Revenue by Country (2021-2026)
  13. 8.6.3 North America Absorbable Hemostatic Materials Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Absorbable Hemostatic Materials Revenue (2021-2032)
  2. 9.2 Europe Absorbable Hemostatic Materials Revenue by Type (2021-2032)
  3. 9.2.1 Europe Absorbable Hemostatic Materials Revenue by Type (2021-2026)
  4. 9.2.2 Europe Absorbable Hemostatic Materials Revenue by Type (2027-2032)
  5. 9.3 Europe Absorbable Hemostatic Materials Revenue Share by Type (2021-2032)
  6. 9.4 Europe Absorbable Hemostatic Materials Revenue by Application (2021-2032)
  7. 9.4.1 Europe Absorbable Hemostatic Materials Revenue by Application (2021-2026)
  8. 9.4.2 Europe Absorbable Hemostatic Materials Revenue by Application (2027-2032)
  9. 9.5 Europe Absorbable Hemostatic Materials Revenue Share by Application (2021-2032)
  10. 9.6 Europe Absorbable Hemostatic Materials Revenue by Country
  11. 9.6.1 Europe Absorbable Hemostatic Materials Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Absorbable Hemostatic Materials Revenue by Country (2021-2026)
  13. 9.6.3 Europe Absorbable Hemostatic Materials Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Absorbable Hemostatic Materials Revenue (2021-2032)
  2. 10.2 China Absorbable Hemostatic Materials Revenue by Type (2021-2032)
  3. 10.2.1 China Absorbable Hemostatic Materials Revenue by Type (2021-2026)
  4. 10.2.2 China Absorbable Hemostatic Materials Revenue by Type (2027-2032)
  5. 10.3 China Absorbable Hemostatic Materials Revenue Share by Type (2021-2032)
  6. 10.4 China Absorbable Hemostatic Materials Revenue by Application (2021-2032)
  7. 10.4.1 China Absorbable Hemostatic Materials Revenue by Application (2021-2026)
  8. 10.4.2 China Absorbable Hemostatic Materials Revenue by Application (2027-2032)
  9. 10.5 China Absorbable Hemostatic Materials Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Absorbable Hemostatic Materials Revenue (2021-2032)
  2. 11.2 Asia Absorbable Hemostatic Materials Revenue by Type (2021-2032)
  3. 11.2.1 Asia Absorbable Hemostatic Materials Revenue by Type (2021-2026)
  4. 11.2.2 Asia Absorbable Hemostatic Materials Revenue by Type (2027-2032)
  5. 11.3 Asia Absorbable Hemostatic Materials Revenue Share by Type (2021-2032)
  6. 11.4 Asia Absorbable Hemostatic Materials Revenue by Application (2021-2032)
  7. 11.4.1 Asia Absorbable Hemostatic Materials Revenue by Application (2021-2026)
  8. 11.4.2 Asia Absorbable Hemostatic Materials Revenue by Application (2027-2032)
  9. 11.5 Asia Absorbable Hemostatic Materials Revenue Share by Application (2021-2032)
  10. 11.6 Asia Absorbable Hemostatic Materials Revenue by Country
  11. 11.6.1 Asia Absorbable Hemostatic Materials Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Absorbable Hemostatic Materials Revenue by Country (2021-2026)
  13. 11.6.3 Asia Absorbable Hemostatic Materials Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Absorbable Hemostatic Materials Revenue (2021-2032)
  2. 12.2 SAMEA Absorbable Hemostatic Materials Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Absorbable Hemostatic Materials Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Absorbable Hemostatic Materials Revenue by Type (2027-2032)
  5. 12.3 SAMEA Absorbable Hemostatic Materials Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Absorbable Hemostatic Materials Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Absorbable Hemostatic Materials Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Absorbable Hemostatic Materials Revenue by Application (2027-2032)
  9. 12.5 SAMEA Absorbable Hemostatic Materials Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Absorbable Hemostatic Materials Revenue by Country
  11. 12.6.1 SAMEA Absorbable Hemostatic Materials Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Absorbable Hemostatic Materials Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Absorbable Hemostatic Materials Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst